Evidence map›Paper›PMID 35919971›Full record

ArticleJournal of environmental quality2022

Impacts of the COVID-19 pandemic on pharmaceuticals in wastewater treated for beneficial reuse: Two case studies in central Pennsylvania.

Kathryn R Hayden, Matthew Jones, Kyle R Elkin, Michael J Shreve, William Irvin Clees, Shirley Clark, Michael L Mashtare, Tamie L Veith, Herschel A Elliott, John E Watson and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of environmental quality, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Kathryn R HaydenDep. of Agricultural and Biological Engineering, The Pennsylvania State Univ., University Park, PA, 16802, USA.
Matthew JonesHuck Institutes of Life Sciences, The Pennsylvania State Univ., University Park, PA, 16802, USA.
Kyle R ElkinUSDA-ARS Pasture Systems & Watershed Management Research Unit, University Park, PA, 16802, USA.ORCID https://orcid.org/0000-0001-5824-8680
Michael J ShreveDep. of Agricultural and Biological Engineering, The Pennsylvania State Univ., University Park, PA, 16802, USA.
William Irvin CleesDep. of Agricultural and Biological Engineering, The Pennsylvania State Univ., University Park, PA, 16802, USA.
Shirley ClarkSchool of Science, Engineering, and Technology, The Pennsylvania State Univ., Harrisburg, PA, 17057, USA.
Michael L MashtareDep. of Agricultural and Biological Engineering, The Pennsylvania State Univ., University Park, PA, 16802, USA.ORCID https://orcid.org/0000-0001-8987-5863
Tamie L VeithUSDA-ARS Pasture Systems & Watershed Management Research Unit, University Park, PA, 16802, USA.ORCID https://orcid.org/0000-0001-7631-0214
Herschel A ElliottDep. of Agricultural and Biological Engineering, The Pennsylvania State Univ., University Park, PA, 16802, USA.
John E WatsonDep. of Ecosystem Science and Management, The Pennsylvania State Univ., University Park, PA, 16802, USA.
Justin SilvermanCollege of Information Science and Technology, The Pennsylvania State Univ., University Park, PA, 16802, USA.
Thomas L RichardDep. of Agricultural and Biological Engineering, The Pennsylvania State Univ., University Park, PA, 16802, USA.ORCID https://orcid.org/0000-0002-0833-4844
Andrew F ReadHuck Institutes of Life Sciences, The Pennsylvania State Univ., University Park, PA, 16802, USA.ORCID https://orcid.org/0000-0001-7604-7903
Heather E PreisendanzDep. of Agricultural and Biological Engineering, The Pennsylvania State Univ., University Park, PA, 16802, USA.ORCID https://orcid.org/0000-0002-2145-2538
Pennsylvania State University · USSoutheast Watershed Research Laboratory · US

Funding

Pennsylvania State Institute for Sustainable Agriculture, Food, and Environmental Science COVID-19 Seed GrantU.S. Department of Agriculture ProjectPEN04574 (Accession#1004448)U.S. Department of Agriculture ProjectPEN04574 (Accession#1004448), ProjectPEN04671 (Accession#1017582)U.S. Department of Agriculture ProjectPEN04671 (Accession#1017582)
6 · The paper itself

Abstract

During the COVID-19 pandemic, wastewater surveillance was leveraged as a powerful tool for monitoring community-scale health. Further, the well-known persistence of some pharmaceuticals through wastewater treatment plants spurred concerns that increased usage of pharmaceuticals during the pandemic would increase the concentrations in wastewater treatment plant effluent. We collected weekly influent and effluent samples from May 2020 through May 2021 from two wastewater treatment plants in central Pennsylvania, the Penn State Water Reclamation Facility and the University Area Joint Authority, that provide effluent for beneficial reuse, including for irrigation. Samples were analyzed for severe acute respiratory syndrome coronavirus 2 (influent only), two over-the-counter medicines (acetaminophen and naproxen), five antibiotics (ampicillin, doxycycline, ofloxacin, sulfamethoxazole, and trimethoprim), two therapeutic agents (remdesivir and dexamethasone), and hydroxychloroquine. Although there were no correlations between pharmaceutical and virus concentration, remdesivir detection occurred when the number of hospitalized patients with COVID-19 increased, and dexamethasone detection co-occurred with the presence of patients with COVID-19 on ventilators. Additionally, Penn State decision-making regarding instruction modes explained the temporal variation of influent pharmaceutical concentrations, with detection occurring primarily when students were on campus. Risk quotients calculated for pharmaceuticals with known effective and lethal concentrations at which 50% of a population is affected for fish, daphnia, and algae were generally low in the effluent; however, some acute risks from sulfamethoxazole were high when students returned to campus. Remdesivir and dexamethasone persisted through the wastewater treatment plants, thereby introducing novel pharmaceuticals directly to soils and surface water. These results highlight connections between human health and water quality and further demonstrate the broad utility of wastewater surveillance.

Indexed as

COVID-19Water Pollutants, ChemicalAcetaminophenAmpicillinAnimalsAnti-Bacterial AgentsDexamethasoneDoxycyclineEnvironmental MonitoringHumansHydroxychloroquineNaproxenOfloxacinPandemicsPennsylvaniaPharmaceutical PreparationsAcetaminophenAmpicillinAnti-Bacterial AgentsDexamethasoneDoxycyclineHydroxychloroquineNaproxenOfloxacinPharmaceutical PreparationsSoilSulfamethoxazoleTrimethoprimWastewaterWater Pollutants, Chemical

Identifiers

PMID35919971
PMCPMC9538887
OpenAlexW4289520511

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.